Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medtronic

How Longevity and Anti-Aging Science Can Help You Live Longer

Is immortality achievable? With longevity science booming, you (or your kids) might make it to age 150. We separate the hype from proven strategies.

Kiplinger

Stocks Showing Rising Market Leadership: Medtronic Earns 83 RS Rating

Medtronic sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Medtronic Stock Gets IBD Rating Lift

A Relative Strength Rating upgrade for Medtronic shows improving technical performance. Will it continue?

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic’s Expansion Gains Momentum—Time for a Market Shift?

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.

MarketBeat

Why Medtronic Just Undercut Its Buy Zone With A 7% Drop

Medtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.

Investors Business Daily

Medtronic taps Renault's CFO to be its new finance chief. How his unusual career path helped land the job

Thierry Piéton will end his CFO tenure at French automaker Renault Group on Feb. 28.

Fortune

Medtronic's Quarterly Earnings Preview: What You Need to Know

Medtronic is poised to release its fiscal third-quarter earnings next month, and analysts project a single-digit profit growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

How we diagnose and define obesity is set to change – here’s why, and what it means for treatment

Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee osteoarthritis.

The Conversation

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Investors Business Daily

3 Stocks Helping to Bring AI to Healthcare

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

MarketBeat

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

MarketBeat

3 MedTech Innovators Revolutionizing Patient Care

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

StockNews.com

Is Medtronic Stock Underperforming the S&P 500?

Although Medtronic has lagged behind the broader S&P 500 index over the past three months, analysts remain moderately optimistic about the stock’s prospects.

Barchart

5 Dividend Aristocrats to Buy Now and Hold Through 2025

The Dividend Aristocrats offer reliable yields; buying them when they are down provides a lever for total returns and a vehicle for market-beating returns.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Medtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond

Medtronic's stock price is in a classic head-and-shoulders reversal that could take it back to record highs within the next two years.

Investors Business Daily

Medtronic Flirts With A Sell Zone After Supplier Issue Trumps Beat And Raise

Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in early trading.

Barchart

Stock Index Futures Slip on Worries Over Russia-Ukraine Escalation, U.S. Housing Data and Walmart Earnings on Tap

December S&P 500 E-Mini futures (ESZ24) are down -0.40%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.32% this morning as risk sentiment took a hit after Russian President Vladimir Putin updated the country’s nuclear doctrine, while investors awaited fresh data on the U.S. housing market and an earnings…

Barchart

Option Volatility And Earnings Report For November 18 - 22

All eyes are on NVDA this week in a highly anticipated earnings report. We also have a few other big names all set to report such as Walmart, Snowflake, Target, Lowe’s, Palo Alto Networks, Deere & Company and Medtronic.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Medtronic Stock: Analyst Estimates & Ratings

Medtronic has lagged behind the broader market over the past year, and analysts remain cautiously bullish on the stock’s prospects.

The Conversation

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

Fortune

Medtronic wants every business unit to have a plan for AI

Companies and organizations from Medtronic to the state of California are deploying AI to improve workflows and outcomes.

Fortune

One company paying out $7.7 million in employee tuition benefits says one change to their program made a huge difference

Medical tech business Medtronic eliminated $7.7 million in student debt, removing its degree requirements, while sending hundreds of employees back to school.

The Conversation

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

Barchart

1 Dividend Aristocrat to Buy at a Discount This September

This dividend-paying stock is trading at an attractive valuation, making it a solid pick for investors seeking value and steady income.

Barchart

How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks?

Medtronic has lagged behind other medical device stocks over the past months, yet Wall Street remains moderately bullish on the stock’s prospects.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.